Literature DB >> 7074500

Recognizing hyperparathyroidism.

T M Murray, R G Josse.   

Abstract

Entities:  

Mesh：

Year:  1982        PMID： 7074500      PMCID： PMC1863299     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  8 in total

1.  Effects of plasma calcium concentration on the relative proportion of hormone and carboxyl fragments in parathyroid venous blood.

Authors:  G P Mayer; J A Keaton; J G Hurst; J F Habener
Journal:  Endocrinology       Date:  1979-06       Impact factor: 4.736

2.  Nonparathyroid humoral hypercalcemia in patients with neoplastic diseases.

Authors:  D Powell; F R Singer; T M Murray; C Minkin; J T Potts
Journal:  N Engl J Med       Date:  1973-07-26       Impact factor: 91.245

3.  Urinary and nephrogenous adenosine 3',5'-monophosphate in the hypercalcemia of malignancy.

Authors:  R K Rude; C F Sharp; R S Fredericks; S B Oldham; N Elbaum; J Link; L Irwin; F R Singer
Journal:  J Clin Endocrinol Metab       Date:  1981-04       Impact factor: 5.958

4.  Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups.

Authors:  A F Stewart; R Horst; L J Deftos; E C Cadman; R Lang; A E Broadus
Journal:  N Engl J Med       Date:  1980-12-11       Impact factor: 91.245

5.  Hypercalcemia in patients with known malignent disease.

Authors:  N A Samaan; R C Hickey; M R Sethi; K P Yang; S Wallace
Journal:  Surgery       Date:  1976-09       Impact factor: 3.982

6.  Mechanisms of hypercalcemia in malignancy.

Authors:  A Besarab; J F Caro
Journal:  Cancer       Date:  1978-06       Impact factor: 6.860

Review 7.  Hypercalcemia and cancer: an update.

Authors:  T M Murray; R G Josse; J N Heersche
Journal:  Can Med Assoc J       Date:  1978-10-21       Impact factor: 8.262

Review 8.  Tumor hypercalcemia and "ectopic hyperparathyroidism".

Authors:  P Skrabanek; J McPartlin; D Powell
Journal:  Medicine (Baltimore)       Date:  1980-07       Impact factor: 1.889
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.